secwatch.observer — SEC 8-K summary
======================================

Issuer:     OCULAR THERAPEUTIX, INC (OCUL)
CIK:        0001393434
Form:       8-K
Filed at:   2021-09-22T23:59:59+00:00
Accession:  0001104659-21-118126
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Ocular Therapeutix elects Merilee Raines to Board of Directors
--------------------------------------------------------------

- Merilee Raines elected to the Board as Class III director effective September 20, 2021.
- She will serve on the Audit Committee and her term expires at the 2023 annual meeting.
- Raines received an option to purchase 36,000 shares at $10.02 per share upon election.
- She previously served as CFO of IDEXX Laboratories from 2003 to 2013.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1393434/000110465921118126/0001104659-21-118126-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1393434/000110465921118126/tm2128101d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-21-118126

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer